During the past decade, Rocky Mountain Movement Disorders Center conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 10 clinical trials were completed, i.e. on average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 7 clinical trials were completed. i.e. 38.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Movement Disorders Center" #1 sponsor was "CHDI Foundation, Inc." with 4 trials, followed by "Enterin Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Biogen" with 2 trials sponsored and "NeuroDerm Ltd." with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Movement Disorders Center" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 4 trials as a collaborator, "The Parkinson Study Group" with 3 trials as a collaborator, "Dr. Glenn T. Stebbins (Rush University Medical Center )" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator and "Syneos Health" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Movement Disorders Center" are "Parkinson Disease" (13 trials), "Parkinson's Disease" (9 trials), "Huntington's Disease" (5 trials), "Huntington Disease" (4 trials) and "Constipation" (3 trials). Many other conditions were trialed in "Rocky Mountain Movement Disorders Center" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Movement Disorders Center" are "Drug" (27 trials), "Other" (5 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Active Investigational Treatment ENT-01" (2 trials), "FuRST 2.0" (2 trials), "20 mg BID of PF-02545920" (1 trials) and "APL-130277" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Movement Disorders Center" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain Movement Disorders Center". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Rocky Mountain Movement Disorders Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Movement Disorders Center, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".